Rhaeos, Inc. is a clinical-stage medical device company based in Evanston, Illinois. It originated from the John A. Rogers Research Group at Northwestern University and focuses on developing FlowSense, a noninvasive, wireless, wearable skin patch technology. This innovative platform is designed to assess and monitor fluid flow subdermally, specifically targeting hydrocephalus, a condition characterized by abnormal cerebrospinal fluid accumulation.
FlowSense offers a continuous, real-time monitoring solution that improves patient care by providing a noninvasive alternative to traditional monitoring methods. The technology aims to reduce hospital visits and complications associated with shunt failures, benefiting both healthcare providers and patients. Rhaeos is backed by significant venture capital funding, including support from the National Institutes of Health and the National Science Foundation, which aids in its clinical development and regulatory efforts. The company employs around 44 people and is led by CEO Anna Lisa Somera, who has a strong background in medical device startups.
